New Centre Launched to Spearhead UK Research in Synthetic Biology
News Dec 23, 2008
Programming biological cells so that they behave like engineering parts is the focus of research at a new UK centre launched with £8 million grant from the Engineering and Physical Sciences Research Council (EPSRC).
The new centre will focus on synthetic biology. This is a field in which engineers work with molecular bioscientists to produce biologically-based parts, by modifying DNA. These parts could be used to build biological devices that could detect the early onset of disease or combat harmful bacterial infections.
Imperial College London in partnership with the London School of Economics and Political Science (LSE) will establish the Centre for Synthetic Biology and Innovation as part of EPSRC's effort to push the UK to the forefront of this field. Imperial's Professor Richard Kitney, Director of the Centre, says this new research facility will bring a wealth of new expertise to the UK. He adds:
"Imperial will recruit the best scientists from the UK and around the world to carry out collaborative research, generate intellectual property for licensing, and ultimately create spinout companies that will play a part in spawning new industries for the UK."
Imperial's Professor Paul Freemont, who is Co-Director of the Centre, says that in the next 20 to 50 years research in this field will get to the point where synthetic biology techniques will have the precision of electronics. Currently, biology is much more complicated and less understood.
He explains: "Our understanding of how living cells work isn't as good as our understanding of electronic devices. We want to get to the stage where we've got all the parts we need to build any biological machine that we want."
Initially, researchers at the Centre will focus on developing standard systems and specifications to create these parts. This will involve modifying DNA, inserting it into cells, and cataloguing what these cells do. These will then be used to assemble devices for use in a range of applications.
One long-term application could include the development of biological micro-processors. These are microscopic biologically based electronic devices that could, for example, be inserted into the body to monitor the health of patients, or detect types of cancer.
Already, researchers at Imperial have developed some important components for use in a biological micro-processor, such as an oscillator, which is a device that keeps time. Scientists are also working on logic circuits for use in microprocessors, called 'AND' gates, made from bacteria.
Another application is the development of sensors to detect harmful bacteria. These sensors are designed to recognize a small molecule that is released when harmful bacteria begin to colonize surfaces.
Scientists say this device could have applications in the food and healthcare industry where samples from wiped surfaces could be placed on the infection detector's chip. This would emit different colored lights to alert the user to the type of bacteria that has infected the surface such as E.coli or MRSA, enabling staff to take remedial action rapidly.
The College will work closely with LSE to inform the public about the research that will be carried out at the Centre. This will involve lectures and outreach activities about the potential benefits of synthetic biology and its public value.
LSE will also train researchers at the Centre in the social, ethical, legal, and political issues surrounding this emerging field. These include examining the social and economic impacts of biotechnology, and developing practices of regulation and good governance
Professor Nikolas Rose, Director of LSE's BIOS Centre, points out that consideration of the social issues has been built in to the very conception of this new centre.
He says: "We have developed a highly innovative link between life scientists and social scientists in teaching and research. Crucially, we believe that informed public debate, with active engagement by the research scientists, is essential if the many benefits of synthetic biology are to be fully realized."
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE